Novo ratchets up 2023 growth forecast on strong Wegovy momentum FiercePharma
Novo ratchets up 2023 growth forecast on strong Wegovy momentum FiercePharma
Avenue touts progress with FDA on embattled pain candidate after ... Endpoints News
Cryopreservation Equipment Market Demand And Growth Drivers, And Analysis Till 2028 openPR
Latest on reverberations of abortion pill ruling; Biotech venture ... Endpoints News
AstraZeneca lines up competition with Merck in lung cancer before ... Endpoints News
Roche's combo therapy reduces risk of liver cancer returning but ... Endpoints News
Legend's new CMO will bring in more cell therapy partners ...
See more here: Nykode Therapeutics announces positive final results from its Phase 2 trial of VB10.16 in combination with PD-L1 inhibitor atezolizumab in advanced...
See the article here: Verb Biotics announces participation in Ginkgo Bioworks’ annual Ferment conference
More: Invitation to Idorsia's Q1 2023 Financial Results webcast and conference call
Recent Comments